MedTrace Logo

Registry Experience at the Washington Hospital Center, DES - Xience V

NCT01003977 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6069

Last updated 2020-01-02

No results posted yet for this study

Summary

Single center registry of patients who have received a Xience V everolimus-eluting stent at the Washington Hospital Center, with the primary objective to assess clinical success and safety at 30 days, 6 months and 1 year post-implantation.

Conditions

Sponsors & Collaborators

  • Rebecca Torguson

    lead OTHER

Principal Investigators

  • Ron Waksman, MD · Medstar Research Institute/Cardiovascular Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2011-09-30
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01003977 on ClinicalTrials.gov